These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19601846)

  • 1. Modulating proteostasis: peptidomimetic inhibitors and activators of protein folding.
    Hatahet F; Ruddock LW
    Curr Pharm Des; 2009; 15(21):2488-507. PubMed ID: 19601846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and chemical approaches to diseases of proteostasis deficiency.
    Powers ET; Morimoto RI; Dillin A; Kelly JW; Balch WE
    Annu Rev Biochem; 2009; 78():959-91. PubMed ID: 19298183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular chaperone functions in protein folding and proteostasis.
    Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
    Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Biology Framework to Illuminate Proteostasis.
    Sebastian RM; Shoulders MD
    Annu Rev Biochem; 2020 Jun; 89():529-555. PubMed ID: 32097570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rise of proteostasis promoters.
    Vega H; Agellon LB; Michalak M
    IUBMB Life; 2016 Dec; 68(12):943-954. PubMed ID: 27797166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteostasis boundary in misfolding diseases of membrane traffic.
    Hutt DM; Powers ET; Balch WE
    FEBS Lett; 2009 Aug; 583(16):2639-46. PubMed ID: 19708088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.
    Brandvold KR; Morimoto RI
    J Mol Biol; 2015 Sep; 427(18):2931-47. PubMed ID: 26003923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial proteostasis balances energy and chaperone utilization efficiently.
    Santra M; Farrell DW; Dill KA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2654-E2661. PubMed ID: 28292901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.
    Carver JA; Ecroyd H; Truscott RJW; Thorn DC; Holt C
    Acc Chem Res; 2018 Mar; 51(3):745-752. PubMed ID: 29442498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular chaperones in protein folding and proteostasis.
    Hartl FU; Bracher A; Hayer-Hartl M
    Nature; 2011 Jul; 475(7356):324-32. PubMed ID: 21776078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
    Fatima MT; Islam Z; Ahmad E; Salahuddin P
    Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative impact of chaperone-mediated folding on genome evolution.
    Bogumil D; Dagan T
    Biochemistry; 2012 Dec; 51(50):9941-53. PubMed ID: 23167595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and biological approaches synergize to ameliorate protein-folding diseases.
    Mu TW; Ong DS; Wang YJ; Balch WE; Yates JR; Segatori L; Kelly JW
    Cell; 2008 Sep; 134(5):769-81. PubMed ID: 18775310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When proteostasis goes bad: Protein aggregation in the cell.
    Radwan M; Wood RJ; Sui X; Hatters DM
    IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.
    Reis SD; Pinho BR; Oliveira JMA
    Mol Neurobiol; 2017 Oct; 54(8):5829-5854. PubMed ID: 27660272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial (Thematic Issue: Targeting Conformational Diseases with Natural and Pharmacological Chaperones).
    Pey AL
    Curr Drug Targets; 2016; 17(13):1454. PubMed ID: 27678341
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.